logo

Therapeutic Plasma Exchange Systems Market Size (2024 - 2029)

The therapeutic plasma exchange systems market is projected to experience significant growth, driven by an increasing prevalence of autoimmune diseases, hematology disorders, and cardiovascular conditions, alongside a rising geriatric population. This expansion in market size is further supported by the growing demand for effective treatments for conditions such as myasthenia gravis, which has seen a notable rise in incidence globally.

Home Market Analysis Healthcare Research Medical Devices Research Therapeutic Plasma Exchange Systems Market Market Size

Market Size of Therapeutic Plasma Exchange Systems Industry

Therapeutic Plasma Exchange Systems Market
Study Period 2019 - 2029
Base Year For Estimation 2023
Forecast Data Period 2024 - 2029
CAGR > 7.50 %
Fastest Growing Market Asia Pacific
Largest Market North America

Major Players

rd-img

*Disclaimer: Major Players sorted in no particular order

Therapeutic Plasma Exchange Market Analysis

The Therapeutic plasma exchange systems market studied was anticipated to grow with a CAGR of nearly 7.5% during the forecast period. The major factor attributing to the growth of the market is an increased number of patients diagnosed with autoimmune diseases, hematology disorders, cardiovascular diseases, and a rise in the geriatric population. For instance, according to the National Institutes of Health report published in the year 2020, the prevalence of myasthenia gravis is increasing in recent decades and affects about 20 per 100,000 people worldwide every year demanding the efficient treatments for the ailments which are likely to fuel the market over the forecast period.

Therapeutic Plasma Exchange Industry Segmentation

Therapeutic plasma exchange (TPE), also known as plasmapheresis is an extracorporeal blood purification technique that removes pathogenic substances such as pathogenic autoantibodies, immune complexes, cryoglobulins and cholesterol-containing lipoproteins from the plasma of patients and replaces with substitution fluid such as albumin solution, or often fresh frozen plasma. TPE is used in the treatment of various autoimmune diseases, renal disorders, hematology disorders, etc, which is likely to drive the growth of the market.

Products
Apheresis Machine
Filters
Others
Indication
Neurological Disorders
Cardiovascular Disorders
Hematology Disorders
Renal Disorders
Others
End-User
Hospitals
Ambulatory Surgical Centers
Others
Geography
North America
United states
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Therapeutic Plasma Exchange Systems Market Size Summary

The therapeutic plasma exchange systems market is poised for significant growth, driven by an increasing prevalence of autoimmune diseases, hematology disorders, and cardiovascular conditions, alongside a rising geriatric population. The demand for effective treatments for conditions such as myasthenia gravis is contributing to this expansion. The neurological disorders segment is expected to generate the largest revenue, attributed to the efficacy of therapeutic plasma exchange in managing conditions like Guillain-Barre syndrome and multiple sclerosis. Meanwhile, the cardiovascular disorders segment is projected to experience the highest growth rate, fueled by the adoption of therapeutic plasma exchange as a primary treatment for arteriosclerosis and rheumatic endocarditis. Technological advancements enhancing the application of therapeutic plasma exchange in removing lipoproteins and inflammatory factors are also expected to propel market growth. Hospitals are anticipated to hold the major market share due to the high number of patients with cardiac, neurological, and renal conditions, supported by favorable reimbursement policies and a shift of physicians from private clinics to larger healthcare facilities.

North America is expected to maintain its dominance in the therapeutic plasma exchange systems market, driven by the rising prevalence of autoimmune disorders and the adoption of lipoprotein apheresis treatments for cardiovascular indications. The region's advanced technology and established healthcare infrastructure further bolster market growth. The market is moderately competitive, with key players like Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B. Braun Melsungen AG, and Fresenius Kabi AG actively expanding their market positions through acquisitions, mergers, and the introduction of new treatment methods. Notably, Terumo BCT's receipt of CE mark approval for its Spectra Optia Apheresis System in Europe highlights the ongoing innovation and regulatory advancements within the industry, contributing to the market's revenue share.

Explore More

Therapeutic Plasma Exchange Systems Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rise in Global Prevalence of Autoimmune and Cardiac Diseases

      2. 1.2.2 Growing R&D Activities and Clinical Trials to Increase the Application in Various Indications

    3. 1.3 Market Restraints

      1. 1.3.1 High Cost of Treatment and Devices

      2. 1.3.2 Lack of Skilled Healthcare Professionals in Emerging Markets

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION

    1. 2.1 Products

      1. 2.1.1 Apheresis Machine

      2. 2.1.2 Filters

      3. 2.1.3 Others

    2. 2.2 Indication

      1. 2.2.1 Neurological Disorders

      2. 2.2.2 Cardiovascular Disorders

      3. 2.2.3 Hematology Disorders

      4. 2.2.4 Renal Disorders

      5. 2.2.5 Others

    3. 2.3 End-User

      1. 2.3.1 Hospitals

      2. 2.3.2 Ambulatory Surgical Centers

      3. 2.3.3 Others

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United states

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle-East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle-East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Therapeutic Plasma Exchange Systems Market Size FAQs

The Therapeutic Plasma Exchange Systems Market is projected to register a CAGR of greater than 7.5% during the forecast period (2024-2029)

Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B. Braun Melsungen AG and Fresenius Kabi AG are the major companies operating in the Therapeutic Plasma Exchange Systems Market.

Therapeutic Plasma Exchange Systems Report Snapshots

Therapeutic Plasma Exchange Systems Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)